236 
CogState Ltd (ASX:CGS) today announced that it has signed a contract with an international pharmaceutical company to participate in a phase 2 clinical trial for the treatment of Major Read all
CogState Signs US$2.6m Clinical Trial Contract
|
Pharmaxis in trading halt
|
TIS get Robust EU Final Clinical Trial Results
Biomedical company, Tissue Therapies Limited (ASX: TIS) has today released the final report from the 44 patient, five site, international clinical trial of VitroGro® ECM for the treatment of venous ulcers. The internationally respected wound care clinician and researcher, Professor Keith Har… Read all
|
Alchemia Limited in trading halt
Alchemia is in a trading halt pending the making of an announcement to the market in relation to the outcome of a propo… Read all
|
Tissue Therapies - Successful FDA Classification and EU Audit
Biomedical company, Tissue Therapies Limited (ASX: TIS) has announced today that it has received formal classification of the VitroGro® synthetic protein as a biologic product from the US Food and Drug Administration (FDA). This is now the usual FDA classification for synthetic protein produc… Read all
|
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use